Enhanced Cellular Uptake with a Cobaltacarborane−Porphyrin−HIV-1 Tat 48−60 Conjugate
journal contributionposted on 19.07.2006 by Martha Sibrian-Vazquez, Erhong Hao, Timothy J. Jensen, M. Graça H. Vicente
Any type of content formally published in an academic journal, usually following a peer-review process.
A series of four porphyrin−cobaltacarborane conjugates have been synthesized, containing three or four cobaltabisdicarbollide anions linked by O(CH2CH2O)2 groups to the porphyrin macrocycle and one of them containing a HIV-1 Tat 48−60 peptide sequence linked via a low molecular weight poly(ethylene glycol) (PEG) spacer. The cellular uptake, cytotoxicity, and preferential sites of intracellular localization of the conjugates were evaluated in human HEp2 cells. All conjugates are nontoxic in the dark at the concentrations studied. Upon exposure to low light dose (1 J cm-2) only the porphyrin−cobaltacarborane−HIV-1 Tat 48−60 conjugate showed 30% inhibition of cell proliferation at a concentration of 10 μM. The cellular uptake was dependent on the number of carborane cages and was significantly enhanced by the presence of the cell penetrating peptide sequence HIV-1 Tat 48−60. All conjugates preferentially localized in the cell lysosomes.